Summary
ATEC Chart
Alphatec Holdings, Inc. (ATEC) Q3 2025 Earnings Call Transcript
Alphatec Holdings, Inc. ( ATEC ) Q3 2025 Earnings Call October 30, 2025 4:30 PM EDT Company Participants Patrick Miles - Executive Chairman, CEO & President J. Koning - Executive VP & CFO Conference Call Participants Vikramjeet Chopra - Wells Fargo Securities, LLC, Research Division Matthew Miksic - Barclays Bank PLC, Research Division Young Li - Jefferies LLC, Research Division Anna Runci - Piper Sandler & Co., Research Division K.
Alphatec (ATEC) Q3 Earnings and Revenues Surpass Estimates
Alphatec (ATEC) came out with quarterly earnings of $0.03 per share, beating the Zacks Consensus Estimate of a loss of $0.03 per share. This compares to a loss of $0.28 per share a year ago.
These 3 health tech stocks spiked 37% in a day; Time to buy?
While the broader stock market suffered steep losses on Friday amid trade policy shifts and troubling economic data, select health technology equities stood out.
Alphatec Holdings Inc. (ATEC) FAQ
What is the stock price today?
On which exchange is it traded?
What is its stock symbol?
Does it pay dividends? What is the current yield?
What is its market cap?
What is the earnings per share?
When is the next earnings date?
Has Alphatec Holdings Inc. ever had a stock split?
Alphatec Holdings Inc. Profile
| - Industry | - Sector | Patrick S. Miles CEO | NASDAQ (NGS) Exchange | 02081G201 CUSIP |
| US Country | 867 Employees | - Last Dividend | 25 Aug 2016 Last Split | 2 Jun 2006 IPO Date |
Overview
Alphatec Holdings, Inc., founded in 1990 and headquartered in Carlsbad, California, is a distinguished medical technology company focused on the design, development, and commercialization of innovative technologies for the surgical treatment of spinal disorders. Operating both in the United States and internationally, Alphatec manufactures and supplies its revolutionary products through a combination of third-party suppliers, independent sales agents, and direct sales representatives. The company's commitment to advancing spinal surgery technologies has positioned it as a leader in its field, offering a wide range of solutions aimed at improving patient outcomes.
Products and Services
- Alpha InformatiX Product Platform – A comprehensive suite of solutions that includes:
- EOS imaging system: Offers full-body imaging for enhanced diagnostic capabilities.
- VEA alignment mobile application: Leverages EOS technology, enabling quick quantification of alignment parameters on mobile devices.
- SafeOp Neural InformatiX System: Automates electromyographic and somatosensory evoked potential monitoring for increased safety.
- Valence: Integrates navigation and robotics into spine procedures, optimizing surgical outcomes.
- Sigma Prone TransPsoas (PTP) Access and PTP Patient Positioning Systems – Designed to improve accessibility and patient positioning during surgery.
- Spinal Implants and Fixation Systems – Includes:
- NanoTec surface modifications: Enhance implant integration and stability.
- Calibrate PSX and Invictus: Offer advanced spinal fixation solutions.
- Standalone implants: Provide options for height restoration and stabilization.
- Biological Solutions – A diverse portfolio of biologics designed to support spinal surgery and healing, comprising:
- 3D ProFuse Osteoconductive Bioscaffold: Facilitates ease of handling and improved endplate contact.
- AlphaGRAFT Demineralized Bone Matrix (DBM): Utilizes demineralized human tissues for bone grafting.
- AlphaGRAFT DBM Fibers: Offers demineralized fibers for versatile use in bone grafts.
- AlphaGRAFT Cellular Bone Matrix (CBM): A growth factor-enriched cellular bone matrix available in various forms for different surgical needs.
- BioCORE Moldable Bioactive Graft: A moldable, synthetic mineral-collagen composite matrix designed to fit bone defects.
- Amnioshield Amniotic Tissue Barrier: An allograft used for spinal surgical barrier applications.
Contact Information
